| Identification | Back Directory | [Name]
H-TYR-PRO-TRP-GLY-NH2 | [CAS]
144450-13-5 | [Synonyms]
YPWG-NH2 TYR-W-MIF-1 TYR-W-MIF-I (TYR0,TRP2)-MIF-I [TYR0, TRP2]-MIF-1 TYR-PRO-TRP-GLY-NH2 H-TYR-PRO-TRP-GLY-NH2 Tyr-W-MIF-I, (Tyr0,Trp2)-MIF-I tyrosyl-prolyl-tryptophyl-glycinamide L-Tyrosyl-L-prolyl-L-tryptophylglycinamide Glycinamide, L-tyrosyl-L-prolyl-L-tryptophyl- tyr-(trp2)-msh release inhibiting*factor trifluor alpha-melanotropin release inhibiting factor, Tyr-[Trp2] (TYR0,TRP2)-MELANOCYTE-STIMULATING HORMONE-RELEASE INHIBITING FACTOR [TYR0, TRP2]-MELANOCYTE STIMULATING HORMONE-RELEASE INHIBITING FACTOR-1 Tyr-[Trp2]-Melanocyte Stimulating Hormone Release Inhibiting Factor trifluoroacetate salt (2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | [Molecular Formula]
C27H32N6O5 | [MDL Number]
MFCD00237151 | [MOL File]
144450-13-5.mol | [Molecular Weight]
520.58 |
| Hazard Information | Back Directory | [Uses]
Tyr-W-MIF-1 is an opioid tetrapeptide with opiate and antiopiate activity. Tyr-W-MIF-1 can induce analgesia[1][2][5]. | [in vivo]
Tyr-W-MIF-1 (i.c.v, 200 μg of 5 μL) induces prolonged analgesia in rats[2].
Tyr-W-MIF-1 (i.t., 0.75 μg) induces analgesia, and is reversed by Naloxone[3].
| Animal Model: | Rats[2] | | Dosage: | 200 μg in 5 μL | | Administration: | Intracerebroventricular injection (i.c.v) | | Result: | Prolonged analgesia, measured by latency to remove the tail from a heating element. |
| [References]
[1] Yang YR, et L. Opioid and antiopioid actions of Tyr-MIF-1, Tyr-W-MIF-1 and hemorphin-4 on rat locus coeruleus neurons: intracellular recording in vitro. Chin J Physiol. 1997 Sep 30;40(3):131-5. PMID:9434888 [2] Gergen KA, et al. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2). Peptides. 1994;15(8):1505-11. DOI:10.1016/0196-9781(94)90130-9 [3] Gergen KA, et al. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors. Eur J Pharmacol. 1996 Mar 18;298(3):235-9. DOI:10.1016/0014-2999(95)00823-3 [4] Harrison LM, et al. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther. 1998 Feb;284(2):611-7. PMID:9454805 [5] Erchegyi J, et al. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1). Peptides. 1992 Jul-Aug;13(4):623-31. DOI:10.1016/0196-9781(92)90165-y |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|